FindTrial
Sign In

Donor lymphocyte infusion for the treatment of leukemia relapse following allogeneic hematopoeitic stem cell transplant

Donor lymphocyte infusion for the treatment of leukemia relapse following allogeneic hematopoeitic stem cell transplant

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-12002912
Enrollment
Unknown
Registered
2012-12-27
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leukemia

Interventions

Case series:therapeutic DLI

Sponsors

Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. leukemia patients undergoing allo-HSCT in complete remission; 2. leukemia relapse after HSCT; 3. without previous DLI for prophylaxis or positive minimal residual disease.

Exclusion criteria

Exclusion criteria: 1. active GVHD; 2. uncontrolled severe infection; 3. organ failure.

Design outcomes

Primary

MeasureTime frame
OS;—

Contacts

Public ContactXiao-Jun Huang
huangxiaojun@bjmu.edu.cn+86 10 88326006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 12, 2026